SEC Form 4 · accession 0001445064-15-000128
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — SVP, Investor Strategy & IRO
Period of report
Sep 1, 2015
Accepted (ET)
Sep 2, 2015 · 7:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 1, 2015 | P | 200 | $84.74 | A | 8,061 | D | |
| Ordinary Shares | holding | — | — | — | 500 | I | By wife | |
| Ordinary Shares | holding | — | — | — | 75 | I | By son (M) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (R) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (S) | |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 4, 2015.